Sanj K Patel sold $2.6M of Kiniksa Pharmaceuticals International (KNSA)

Executed May 1, disclosed May 1, the same day.

Value, as filed

$2.6M

48,565 sh × $54.02

Executed

May 1

the trade date, as filed

Disclosed

May 1

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Sanj K Patel CHAIRMAN & CEO profile →

Sanj K Patel (CHAIRMAN & CEO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $26.4M of KNSA (508,339 sh across 6 lots, as filed), executed Apr 28.

The name

KNSA

Kiniksa Pharmaceuticals International, plc KNSA · Healthcare · 68 filings in 24 months ticker →

Healthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Sanj K Patel in KNSA

KNSASALE Kiniksa Pharmaceuticals International, plc $26.4M
508,339 sh across 6 lots
Exec Apr 28
Filed Apr 30 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $364K
7,278 sh × $50.01
Exec Apr 6
Filed Apr 8 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $10.0M
257,969 sh across 4 lots
Exec Oct 20 2025
Filed Oct 22 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $2.3M
86,270 sh across 3 lots
Exec May 23 2025
Filed May 28 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $163K
6,029 sh × $27.05
Exec May 9 2025
Filed May 9 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $2.1M
89,561 sh × $23.00
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET